DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 8Dr. Reddy's Laboratories
02 6Alfred E Tiefenbacher GmbH
03 3Mankind Pharma
04 1#NAME?
05 6Accord healthcare
06 3Adalvo
07 3Alkem Laboratories
08 28Amgen Inc
09 3Amneal Pharmaceuticals
10 2Anabiosis S.A.
11 3Annora Pharma
12 1Apotex Inc
13 4Auro Pharma Inc
14 3Aurobindo Pharma Limited
15 1Avansor Pharma Oy
16 2CLONMEL HLTHCARE
17 3Celgene Corporation
18 2GSK
19 4Glenmark Pharmaceuticals
20 3Grindeks AS
21 3Intas Pharmaceuticals
22 4JAMP PHARMA
23 6Krka
24 3MSN Laboratories
25 3Macleods Pharmaceuticals Limited
26 2Norameda
27 1Noucor
28 1Pharmascience Inc.
29 2Reddy Pharma Iberia Sa
30 10STADA Arzneimittel
31 10Sandoz B2B
32 3Shilpa Medicare
33 1Skm Strategic Medicine Sl
34 2Tarbis Farma Sl
35 3Tecnimede
36 7Teva Pharmaceutical Industries
37 8Torrent Pharmaceuticals Limited
38 3Unichem Pharmaceuticals USA, Inc
39 7Zentiva
40 3Zydus Pharmaceuticals
01 3Coated Tablet
02 1FCT
03 70Film Coated Tablet
04 3Film Coated Tablet
05 12Film-Coated Tablet
06 3Oral Solid Dosage Form
07 19TABLET
08 1TABLET, EXTENDED RELEASE;ORAL
09 51TABLET;ORAL
10 3Tablet
11 5Blank
01 2Allowed
02 23Approved
03 11Authorised
04 23Authorized
05 24DISCN
06 6EU Dossier Readiness-Q3 2020
07 3Lead Market Dossiers- Filed
08 2Marketed
09 1Originator
10 31Prescription
11 19RX
12 26Blank
01 1APO-APREMILAST
02 42APREMILAST
03 4AURO-APREMILAST
04 1Apremilast +Pharma
05 6Apremilast Accord
06 2Apremilast Anabiosis
07 1Apremilast Avansor
08 2Apremilast Clonmel
09 2Apremilast Dr. Reddy'S
10 2Apremilast Glenmark
11 6Apremilast Krka
12 1Apremilast Noucor
13 2Apremilast Reddy
14 6Apremilast Sandoz
15 6Apremilast Stada
16 2Apremilast Stada Arzneimittel Ag
17 2Apremilast Stada Nordic
18 2Apremilast Tarbis
19 4Apremilast Teva
20 2Apremilast Torrent
21 4Apremilast Zentiva
22 1GLN-APREMILAST
23 2Imaplix
24 4JAMP APREMILAST
25 13OTEZLA
26 1OTEZLA XR
27 16Otezla
28 1Otezla 30mg
29 1PMS-APREMILAST
30 2Phomilot
31 4SANDOZ APREMILAST
32 2Supota
33 24Blank
01 2Australia
02 19Canada
03 3Czech Republic
04 12Estonia
05 6Germany
06 9India
07 3Latvia
08 11Malta
09 2Norway
10 3Portugal
11 1South Africa
12 23Spain
13 23Sweden
14 2Switzerland
15 52USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : APREMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2023-07-14
Application Number : 211756
Regulatory Info : DISCN
Registration Country : USA
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q3 2020
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q3 2020
Registration Country : Germany
Delivering quality and niche Active Pharmaceutical Ingredients across the global from our USFDA-approved facility.
Regulatory Info : RX
Registration Country : USA
Brand Name : APREMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2024-02-07
Application Number : 211734
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : APREMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 20MG
Packaging :
Approval Date : 2023-07-14
Application Number : 211756
Regulatory Info : DISCN
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : APREMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2023-07-14
Application Number : 211756
Regulatory Info : DISCN
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 20MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Authorised
Registration Country : Malta
Brand Name : Apremilast Reddy
Dosage Form : Film Coated Tablet
Dosage Strength : 30MG
Packaging :
Approval Date : 2025-06-20
Application Number :
Regulatory Info : Authorised
Registration Country : Malta
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Authorised
Registration Country : Malta
Brand Name : Apremilast Reddy
Dosage Form : Film Coated Tablet
Dosage Strength : 10MG; 20MG; 30MG
Packaging :
Approval Date : 2025-06-20
Application Number :
Regulatory Info : Authorised
Registration Country : Malta
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q3 2020
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 20MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q3 2020
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q3 2020
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q3 2020
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q3 2020
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q3 2020
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q3 2020
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 20MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q3 2020
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q3 2020
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q3 2020
Registration Country : Germany
Delivering quality and niche Active Pharmaceutical Ingredients across the global from our USFDA-approved facility.
Regulatory Info : RX
Registration Country : USA
Brand Name : APREMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 20MG
Packaging :
Approval Date : 2024-02-07
Application Number : 211734
Regulatory Info : RX
Registration Country : USA
Delivering quality and niche Active Pharmaceutical Ingredients across the global from our USFDA-approved facility.
Regulatory Info : RX
Registration Country : USA
Brand Name : APREMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2024-02-07
Application Number : 211734
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : OTEZLA
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2014-03-21
Application Number : 205437
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : OTEZLA
Dosage Form : TABLET;ORAL
Dosage Strength : 20MG
Packaging :
Approval Date : 2014-03-21
Application Number : 205437
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : OTEZLA
Dosage Form : TABLET;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2014-03-21
Application Number : 205437
Regulatory Info : RX
Registration Country : USA
